United States spent $162 million on remdesivir development but holds no patents, review finds ...Middle East

Washington Post - Economy
Members of Congress asked for a GAO review of taxpayer spending that went toward to Gilead's coronavirus drug.

Read More Details
Finally We wish PressBee provided you with enough information of ( United States spent $162 million on remdesivir development but holds no patents, review finds )

Apple Storegoogle play

Also on site :

Most viewed in Economy


Latest News